Germany · Delayed Price · Currency is EUR EMV Capital Company Description
EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments.
The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors.
It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases.
Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States.
It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries.
The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded in 2018 and is based in London, United Kingdom with additional office in London, United Kingdom.
| Country | United Kingdom |
| Founded | 2018 |
| Industry | Investors, not elsewhere classified |
| Employees | 24 |
| CEO | Ilian Iliev |
Contact Details
Address: 2nd Floor London, W1S 3AN United Kingdom | |
| Phone | 44 (0) 20 3011 2234 |
| Website | emvcapital.com |
Stock Details
| Ticker Symbol | NTK1 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Ilian Iliev | Chief Executive Officer |
| Stephen Crowe | Chief Financial Officer |